Brian Johnson1, Mark Hallett1, Semyon Slobounov2. 1. From the Department of Kinesiology (B.J., S.S.), Pennsylvania State University, University Park; Department of Neurosurgery (S.S.), Penn State Milton S. Hershey Medical Center, Hershey, PA; and National Institutes of Health (M.H., S.S.), National Institute of Neurological Disorders and Stroke, Bethesda, MD. 2. From the Department of Kinesiology (B.J., S.S.), Pennsylvania State University, University Park; Department of Neurosurgery (S.S.), Penn State Milton S. Hershey Medical Center, Hershey, PA; and National Institutes of Health (M.H., S.S.), National Institute of Neurological Disorders and Stroke, Bethesda, MD. sms18@psu.edu.
Abstract
OBJECTIVE: To expand on our previous study by performing a follow-up testing session in the subacute phase of injury for participants recently diagnosed with a concussion. METHODS: A battery of oculomotor tests were administered to participants 30 days postconcussion while simultaneous fMRI was performed. RESULTS: Three of the 7 oculomotor tasks (antisaccade, self-paced saccade, and memory-guided saccade) administered showed significant differences between the recently concussed group compared with normal volunteers. However, performance in these 3 tasks did show improvement from the acute phase of injury. The fMRI analysis revealed significant differences in brain activation patterns compared with normal volunteers, with the concussed group still demonstrating increased and larger areas of activation. Similar to the oculomotor performance, the fMRI analysis showed that at 30 days postinjury, the concussed group more closely mirrored that of the normal volunteer group compared with at 7 days following insult. CONCLUSIONS: Even at 30 days postinjury, and despite being clinically asymptomatic, advanced techniques are able to detect subtle lingering alterations in the concussed brain. Therefore, progressive neuroimaging techniques such as fMRI in conjunction with assessment of oculomotor performance may be beneficial in clinical management of concussion.
OBJECTIVE: To expand on our previous study by performing a follow-up testing session in the subacute phase of injury for participants recently diagnosed with a concussion. METHODS: A battery of oculomotor tests were administered to participants 30 days postconcussion while simultaneous fMRI was performed. RESULTS: Three of the 7 oculomotor tasks (antisaccade, self-paced saccade, and memory-guided saccade) administered showed significant differences between the recently concussed group compared with normal volunteers. However, performance in these 3 tasks did show improvement from the acute phase of injury. The fMRI analysis revealed significant differences in brain activation patterns compared with normal volunteers, with the concussed group still demonstrating increased and larger areas of activation. Similar to the oculomotor performance, the fMRI analysis showed that at 30 days postinjury, the concussed group more closely mirrored that of the normal volunteer group compared with at 7 days following insult. CONCLUSIONS: Even at 30 days postinjury, and despite being clinically asymptomatic, advanced techniques are able to detect subtle lingering alterations in the concussed brain. Therefore, progressive neuroimaging techniques such as fMRI in conjunction with assessment of oculomotor performance may be beneficial in clinical management of concussion.
Authors: Paul McCrory; Willem H Meeuwisse; Mark Aubry; Bob Cantu; Jirí Dvorák; Ruben J Echemendia; Lars Engebretsen; Karen Johnston; Jeffrey S Kutcher; Martin Raftery; Allen Sills; Brian W Benson; Gavin A Davis; Richard G Ellenbogen; Kevin Guskiewicz; Stanley A Herring; Grant L Iverson; Barry D Jordan; James Kissick; Michael McCrea; Andrew S McIntosh; David Maddocks; Michael Makdissi; Laura Purcell; Margot Putukian; Kathryn Schneider; Charles H Tator; Michael Turner Journal: Br J Sports Med Date: 2013-04 Impact factor: 13.800
Authors: Heather G Belanger; Glenn Curtiss; Jason A Demery; Brian K Lebowitz; Rodney D Vanderploeg Journal: J Int Neuropsychol Soc Date: 2005-05 Impact factor: 2.892
Authors: Marcus H Heitger; Tim J Anderson; Richard D Jones; John C Dalrymple-Alford; Chris M Frampton; Michael W Ardagh Journal: Brain Date: 2004-01-21 Impact factor: 13.501
Authors: Marilyn F Kraus; Deborah M Little; Alison J Donnell; James L Reilly; Narina Simonian; John A Sweeney Journal: Cogn Behav Neurol Date: 2007-09 Impact factor: 1.600
Authors: Steven W Zonner; Keisuke Ejima; Ciara C Fulgar; Carmen N Charleston; Megan E Huibregtse; Zachary W Bevilacqua; Keisuke Kawata Journal: JAMA Ophthalmol Date: 2019-03-01 Impact factor: 7.389
Authors: Nicholas G Murray; Brian Szekely; Arthur Islas; Barry Munkasy; Russell Gore; Marian Berryhill; Rebecca J Reed-Jones Journal: J Neurotrauma Date: 2019-10-11 Impact factor: 5.269
Authors: Kathryn L Van Pelt; Andrew P Lapointe; Michelle C Galdys; Lauren A Dougherty; Thomas A Buckley; Steven P Broglio Journal: J Athl Train Date: 2019-05-14 Impact factor: 2.860
Authors: Sarah B Rockswold; Philip C Burton; Amy Chang; Nova McNally; Andrea Grant; Gaylan L Rockswold; Walter C Low; Lynn E Eberly; Essa Yacoub; Christophe Lenglet Journal: J Neurotrauma Date: 2018-08-28 Impact factor: 5.269
Authors: Patricia R Roby; Kristina B Metzger; Catherine C McDonald; Daniel J Corwin; Colin M Huber; Declan A Patton; Susan S Margulies; Matthew F Grady; Christina L Master; Kristy B Arbogast Journal: Phys Sportsmed Date: 2021-09-21 Impact factor: 2.241
Authors: Shih-Wei Liu; Liang-Chung Huang; Wu-Fu Chung; Hsuan-Kan Chang; Jau-Ching Wu; Li-Fu Chen; Yu-Chun Chen; Wen-Cheng Huang; Henrich Cheng; Su-Shun Lo Journal: Int J Environ Res Public Health Date: 2017-02-25 Impact factor: 3.390